Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells

Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells

Abstract Objective Hepatocellular carcinoma (HCC) is one cancer with high death rates. Nowadays, there are no effective drugs to treat it. Cyclovirobuxine D (CVB-D) is the primary ingredient of the traditional Chinese medicine (TCM) Buxus microphylla. Here, we try to explore the impacts of CVB-D on...

Full description

Bibliographic Details
Main Authors: Xinru Jiang, Hongdan Li, Yang Liu
Format: Article
Language:English
Published: Springer 2024-04-01
Series:Discover Oncology
Subjects:
Hepatocellular carcinoma
Cyclovirobuxine D
Ferroptosis
Lipid peroxidation
Online Access:https://doi.org/10.1007/s12672-024-00940-2

Internet

https://doi.org/10.1007/s12672-024-00940-2

Similar Items